{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T04:57:34Z","timestamp":1790312254093,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2017,12,2]],"date-time":"2017-12-02T00:00:00Z","timestamp":1512172800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research","doi-asserted-by":"publisher","award":["BSC0115"],"award-info":[{"award-number":["BSC0115"]}],"id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1007\/s11010-017-3239-y","type":"journal-article","created":{"date-parts":[[2017,12,2]],"date-time":"2017-12-02T10:32:04Z","timestamp":1512210724000},"page":"149-160","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["Alpha-synuclein aggregation, Ubiquitin proteasome system impairment, and l-Dopa response in zinc-induced Parkinsonism: resemblance to sporadic Parkinson\u2019s disease"],"prefix":"10.1007","volume":"444","author":[{"given":"Vinod","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepali","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brajesh Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shweta","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Namrata","family":"Mittra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh Roshan","family":"Jha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devendra Kumar","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chetna","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,12,2]]},"reference":[{"key":"3239_CR1","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1172\/JCI200317575","volume":"111","author":"TM Dawson","year":"2003","unstructured":"Dawson TM, Dawson VL (2003) Rare genetic mutations shed light on the pathogenesis of Parkinson disease. J Clin Invest 111:145\u2013151","journal-title":"J Clin Invest"},{"key":"3239_CR2","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.mrfmmm.2008.10.011","volume":"667","author":"L Migliore","year":"2009","unstructured":"Migliore L, Coppede F (2009) Genetics, environmental factors and the emerging role of epigenetics in neurodegenerative diseases. Mutat Res 667:82\u201397","journal-title":"Mutat Res"},{"issue":"Suppl 1","key":"3239_CR3","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1007\/s10654-011-9581-6","volume":"26","author":"K Wirdefeldt","year":"2011","unstructured":"Wirdefeldt K, Adami HO, Cole P, Trichopoulos D, Mandel J (2011) Epidemiology and etiology of Parkinson\u2019s disease: a review of the evidence. Eur J Epidemiol 26(Suppl 1):S1\u2013S58","journal-title":"Eur J Epidemiol"},{"key":"3239_CR4","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1111\/j.1471-4159.1989.tb07264.x","volume":"52","author":"DT Dexter","year":"1989","unstructured":"Dexter DT, Wells FR, Lees AJ, Agid F, Agid Y, Jenner P, Marsden CD (1989) Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson\u2019s disease. J Neurochem 52:1830\u20131836","journal-title":"J Neurochem"},{"key":"3239_CR5","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.brainres.2011.12.028","volume":"1438","author":"A Kumar","year":"2012","unstructured":"Kumar A, Singh BK, Ahmad I, Shukla S, Patel DK, Srivastava G, Kumar V, Pandey HP, Singh C (2012) Involvement of NADPH oxidase and glutathione in zinc-induced dopaminergic neurodegeneration in rats: similarity with paraquat neurotoxicity. Brain Res 1438:48\u201364","journal-title":"Brain Res"},{"key":"3239_CR6","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1007\/s12035-015-9137-y","volume":"53","author":"V Kumar","year":"2016","unstructured":"Kumar V, Singh BK, Chauhan AK, Singh D, Patel DK, Singh C (2016) Minocycline rescues from zinc-induced nigrostriatal dopaminergic neurodegeneration: biochemical and molecular interventions. Mol Neurobiol 53:2761\u20132777","journal-title":"Mol Neurobiol"},{"key":"3239_CR7","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.3109\/10715762.2011.607164","volume":"45","author":"BK Singh","year":"2011","unstructured":"Singh BK, Kumar A, Ahmad I, Kumar V, Patel DK, Jain SK, Singh C (2011) Oxidative stress in zinc-induced dopaminergic neurodegeneration: implications of superoxide dismutase and heme oxygenase-1. Free Radic Res 45:1207\u20131222","journal-title":"Free Radic Res"},{"key":"3239_CR8","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1073\/pnas.95.11.6469","volume":"95","author":"MG Spillantini","year":"1998","unstructured":"Spillantini MG, Crowther RA, Jakes R, Hasegawa M, Goedert M (1998) Alpha-synuclein in filamentous inclusions of Lewy bodies from Parkinson\u2019s disease and dementia with Lewy bodies. Proc Natl Acad Sci USA 95:6469\u20136473","journal-title":"Proc Natl Acad Sci USA"},{"key":"3239_CR9","first-page":"1720621","volume":"2016","author":"L Xu","year":"2016","unstructured":"Xu L, Pu J (2016) Alpha-synuclein in Parkinson\u2019s disease: from pathogenetic dysfunction to potential clinical application. Parkinson\u2019s Disease 2016:1720621","journal-title":"Parkinson\u2019s Disease"},{"key":"3239_CR10","doi-asserted-by":"crossref","first-page":"a009399","DOI":"10.1101\/cshperspect.a009399","volume":"2","author":"L Stefanis","year":"2012","unstructured":"Stefanis L (2012) Alpha-synuclein in Parkinson\u2019s disease. Cold Spring Harb Perspect Med 2:a009399","journal-title":"Cold Spring Harb Perspect Med"},{"key":"3239_CR11","doi-asserted-by":"crossref","first-page":"845618","DOI":"10.1155\/2012\/845618","volume":"2012","author":"J Blesa","year":"2012","unstructured":"Blesa J, Phani S, Jackson-Lewis V, Przedborski S (2012) Classic and new models of Parkinson\u2019s disease. J Biomed Biotechnol 2012:845618","journal-title":"J Biomed Biotechnol"},{"key":"3239_CR12","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.2174\/1871527315666160920160512","volume":"15","author":"H Javed","year":"2016","unstructured":"Javed H, Kamal MA, Ojha S (2016) An overview on the role of alpha-synuclein in experimental models of Parkinson\u2019s disease from pathogenesis to therapeutics. CNS Neurol Disord Drug Targets 15:1240\u20131252","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"3239_CR13","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1471-4159.2004.02728.x","volume":"91","author":"M Yamada","year":"2004","unstructured":"Yamada M, Iwatsubo T, Mizuno Y, Mochizuki H (2004) Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson\u2019s disease. J Neurochem 91:451\u2013461","journal-title":"J Neurochem"},{"key":"3239_CR14","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.neuron.2006.09.026","volume":"52","author":"VM Lee","year":"2006","unstructured":"Lee VM, Trojanowski JQ (2006) Mechanisms of Parkinson\u2019s disease linked to pathological alpha-synuclein: new targets for drug discovery. Neuron 52:33\u201338","journal-title":"Neuron"},{"key":"3239_CR15","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1385\/NMM:4:1-2:95","volume":"4","author":"DJ Moore","year":"2003","unstructured":"Moore DJ, Dawson VL, Dawson TM (2003) Role for the ubiquitin-proteasome system in Parkinson\u2019s disease and other neurodegenerative brain amyloidoses. Neuromolecular Med 4:95\u2013108","journal-title":"Neuromolecular Med"},{"key":"3239_CR16","doi-asserted-by":"crossref","first-page":"5659","DOI":"10.1038\/ncomms6659","volume":"5","author":"D Vilchez","year":"2014","unstructured":"Vilchez D, Saez I, Dillin A (2014) The role of protein clearance mechanisms in organismal ageing and age-related diseases. Nat Commun 5:5659","journal-title":"Nat Commun"},{"key":"3239_CR17","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1006\/exnr.2002.8050","volume":"179","author":"KS McNaught","year":"2003","unstructured":"McNaught KS, Belizaire R, Isacson O, Jenner P, Olanow CW (2003) Altered proteasomal function in sporadic Parkinson\u2019s disease. Exp Neurol 179:38\u201346","journal-title":"Exp Neurol"},{"key":"3239_CR18","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000367694","volume":"14","author":"C Zheng","year":"2014","unstructured":"Zheng C, Geetha T, Babu JR (2014) Failure of ubiquitin proteasome system: risk for neurodegenerative diseases. Neurodegener Dis 14:161\u2013175","journal-title":"Neurodegener Dis"},{"key":"3239_CR19","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0304-3940(00)01701-8","volume":"297","author":"KS McNaught","year":"2001","unstructured":"McNaught KS, Jenner P (2001) Proteasomal function is impaired in substantia nigra in Parkinson\u2019s disease. Neurosci Lett 297:191\u2013194","journal-title":"Neurosci Lett"},{"key":"3239_CR20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0896-6273(01)00177-5","volume":"29","author":"NY Sherman","year":"2001","unstructured":"Sherman NY, Goldberg AL (2001) Cellular defenses against unfolded proteins: a cell biologist thinks about neurodegenerative diseases. Neuron 29:15\u201332","journal-title":"Neuron"},{"key":"3239_CR21","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.nbd.2006.02.012","volume":"23","author":"XF Wang","year":"2006","unstructured":"Wang XF, Li S, Chou AP, Bronstein JM (2006) Inhibitory effects of pesticides on proteasome activity: implication in Parkinson\u2019s disease. Neurobiol Dis 23:198\u2013205","journal-title":"Neurobiol Dis"},{"key":"3239_CR22","doi-asserted-by":"crossref","first-page":"S17S27","DOI":"10.1016\/j.expneurol.2004.08.021","volume":"191","author":"R Betarbet","year":"2005","unstructured":"Betarbet R, Sherer TB, Greenamyre JT (2005) Ubiquitin-proteasome system and Parkinson\u2019s diseases. Exp Neurol 191:S17\u2013S27","journal-title":"Exp Neurol"},{"key":"3239_CR23","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1073\/pnas.0409713102","volume":"102","author":"F Fornai","year":"2005","unstructured":"Fornai F, Schluter OM, Lenzi P, Gesi M, Ruffoli R, Ferrucci M, Lazzeri G, Busceti CL, Pontarelli F, Battaglia G, Pellegrini A, Nicoletti F, Ruggieri S, Paparelli A, Sudhof TC (2005) Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin-proteasome system and alpha-synuclein. Proc Natl Acad Sci USA 102:3413\u20133418","journal-title":"Proc Natl Acad Sci USA"},{"key":"3239_CR24","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1080\/15287390701459262","volume":"70","author":"W Yang","year":"2007","unstructured":"Yang W, Tiffany-Castiglioni E (2007) The bipyridyl herbicide paraquat induces proteasome dysfunction in human neuroblastoma SH-SY5Y cells. J Toxicol Environ Health A 70:1849\u20131857","journal-title":"J Toxicol Environ Health A"},{"key":"3239_CR25","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jphs.2015.09.003","volume":"129","author":"Y Izumi","year":"2015","unstructured":"Izumi Y, Yamamoto N, Matsushima S, Yamamoto T, Takada-Takatori Y, Akaike A, Kume T (2015) Compensatory role of the Nrf2-ARE pathway against paraquat toxicity: relevance of 26S proteasome activity. J Pharmacol Sci 129:150\u2013159","journal-title":"J Pharmacol Sci"},{"key":"3239_CR26","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1007\/s11064-016-2052-4","volume":"42","author":"GF Kwakye","year":"2017","unstructured":"Kwakye GF, McMinimy RA, Aschner M (2017) Disease-toxicant interactions in Parkinson\u2019s disease neuropathology. Neurochem Res 42:1772\u20131786","journal-title":"Neurochem Res"},{"key":"3239_CR27","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s12035-014-8696-7","volume":"51","author":"S Agrawal","year":"2015","unstructured":"Agrawal S, Singh A, Tripathi P, Mishra M, Singh MP, Singh MP (2015) Cypermethrin-induced nigrostriatal dopaminergic neurodegeneration alters the mitochondrial function: a proteomics study. Mol Neurbiol 51:448\u2013465","journal-title":"Mol Neurbiol"},{"key":"3239_CR28","doi-asserted-by":"crossref","first-page":"950","DOI":"10.3109\/10715762.2010.492832","volume":"44","author":"A Kumar","year":"2010","unstructured":"Kumar A, Ahmad I, Shukla S, Singh BK, Patel DK, Pandey HP, Singh C (2010) Effect of zinc and paraquat co-exposure on neurodegeneration: modulation of oxidative stress and expression of metallothioneins, toxicant responsive and transporter genes in rats. Free Radic Res 44:950\u2013965","journal-title":"Free Radic Res"},{"key":"3239_CR29","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-017-0491-9","author":"P Tripathi","year":"2017","unstructured":"Tripathi P, Singh A, Bala L, Patel DK, Singh MP (2017) Ibuprofen protects from cypermethrin-induced changes in the striatal dendritic length and spine density. Mol Neurobiol. https:\/\/doi.org\/10.1007\/s12035-017-0491-9","journal-title":"Mol Neurobiol"},{"key":"3239_CR30","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1093\/hmg\/ddm249","volume":"16","author":"W Yang","year":"2007","unstructured":"Yang W, Chen L, Ding Y, Zhuang X, Kang UJ (2007) Paraquat induces dopaminergic dysfunction and proteasome impairment in DJ-1 deficient mice. Hum Mol Genet 16:2900\u20132910","journal-title":"Hum Mol Genet"},{"key":"3239_CR31","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"OH Lowry","year":"1951","unstructured":"Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265\u2013275","journal-title":"J Biol Chem"},{"key":"3239_CR32","doi-asserted-by":"crossref","first-page":"5782","DOI":"10.1007\/s12035-015-9478-6","volume":"53","author":"AK Chauhan","year":"2016","unstructured":"Chauhan AK, Mittra N, Kumar V, Patel DK, Singh C (2016) Inflammation and B-cell lymphoma-2 associated X protein regulate zinc-induced apoptotic degeneration of rat nigrostriatal dopaminergic neurons. Mol Neurobiol 53:5782\u20135795","journal-title":"Mol Neurobiol"},{"key":"3239_CR33","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1038\/sj.cdd.4401705","volume":"12","author":"Z Gu","year":"2005","unstructured":"Gu Z, Nakamura T, Yao D, Shi ZQ, Lipton SA (2005) Nitrosative and oxidative stress links dysfunctional ubiquitination to Parkinson\u2019s disease. Cell Death Differ 12:1202\u20131204","journal-title":"Cell Death Differ"},{"key":"3239_CR34","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1110\/ps.9.12.2489","volume":"9","author":"TD Kim","year":"2000","unstructured":"Kim TD, Paik SR, Yang CH, Kim J (2000) Structural changes in alpha-synuclein affect its chaperone-like activity in vitro. Protein Sci 9:2489\u20132496","journal-title":"Protein Sci"},{"key":"3239_CR35","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1007\/s12035-014-8954-8","volume":"52","author":"S Agrawal","year":"2015","unstructured":"Agrawal S, Dixit A, Singh A, Tripathi P, Singh D, Patel DK, Singh M.P (2015) Cyclosporin A and MnTMPyP alleviate \u03b1-synuclein expression and aggregation in cypermethrin-induced Parkinsonism. Mol Neurobiol 52:1619\u20131628","journal-title":"Mol Neurobiol"},{"key":"3239_CR36","doi-asserted-by":"crossref","first-page":"11753","DOI":"10.1074\/jbc.M208641200","volume":"278","author":"H Snyder","year":"2003","unstructured":"Snyder H, Mensah K, Theisler C, Lee J, Matouschek A, Wolozin B (2003) Aggregated and monomeric alpha-synuclein bind to the S6\u2032 proteasomal protein and inhibit proteasomal function. J Biol Chem 278:11753\u201311759","journal-title":"J Biol Chem"},{"key":"3239_CR37","doi-asserted-by":"crossref","first-page":"10710","DOI":"10.1074\/jbc.M308434200","volume":"279","author":"H Sawada","year":"2004","unstructured":"Sawada H, Kohno R, Kihara T, Izumi Y, Sakka N, Ibi M, Nakanishi M, Nakamizo T, Yamakawa K, Shibasaki H, Yamamoto N, Akaike A, Inden M, Kitamura Y, Taniguchi T, Shimohama S (2004) Proteasome mediates dopaminergic neuronal degeneration and its inhibition causes alpha-synuclein inclusions. J Biol Chem 279:10710\u201310719","journal-title":"J Biol Chem"},{"key":"3239_CR38","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/j.1471-4159.2009.06401.x","volume":"111","author":"M Chen","year":"2009","unstructured":"Chen M, Chen Q, Cheng XW, Lu TJ, Jia JM, Zhang C, Xiong ZQ (2009) Zn2 + mediates ischemia-induced impairment of the Ubiquitin-proteasome system in the rat hippocampus. J Neurochem 111:1094\u20131103","journal-title":"J Neurochem"},{"issue":"Suppl 2","key":"3239_CR39","first-page":"II19","volume":"249","author":"R Katzenschlager","year":"2002","unstructured":"Katzenschlager R, Lees AJ (2002) Treatment of Parkinson\u2019s disease: levodopa as the first choice. J Neurol 249(Suppl 2):II19\u2013I24","journal-title":"J Neurol"},{"key":"3239_CR40","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.neuropharm.2012.06.012","volume":"63","author":"P Huot","year":"2012","unstructured":"Huot P, Johnston TH, Koprich JB, Fox SH, Brotchie JM (2012) l-DOPA pharmacokinetics in the MPTP-lesioned macaque model of Parkinson\u2019s disease. Neuropharmacology 63:829\u2013836","journal-title":"Neuropharmacology"},{"key":"3239_CR41","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1046\/j.1471-4159.2000.741229.x","volume":"74","author":"DM Camp","year":"2000","unstructured":"Camp DM, Loeffler DA, LeWitt PA (2000) l-DOPA does not enhance hydroxyl radical formation in the nigrostriatal dopamine system of rats with a unilateral 6-hydroxydopamine lesion. J Neurochem 74:1229\u20131240","journal-title":"J Neurochem"},{"key":"3239_CR42","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/mds.1091","volume":"16","author":"KP Datla","year":"2001","unstructured":"Datla KP, Blunt SB, Dexter DT (2001) Chronic l-DOPA administration is not toxic to the remaining dopaminergic nigrostriatal neurons, but instead may promote their functional recovery, in rats with partial 6-OHDA or FeCl(3) nigrostriatal lesions. Mov Disord 16:424\u2013434","journal-title":"Mov Disord"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11010-017-3239-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-017-3239-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-017-3239-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T17:04:07Z","timestamp":1660064647000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11010-017-3239-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,2]]},"references-count":42,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["3239"],"URL":"https:\/\/doi.org\/10.1007\/s11010-017-3239-y","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,2]]}}}